You just read:

Resverlogix Announces Third Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone and Provides an Update on Corporate Activities

News provided by

Resverlogix Corp.

Mar 17, 2017, 07:00 ET